Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
Clinical trial NCT00813228 · COMPLETED
Trial details
- NCT number
- NCT00813228
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-06
- Primary completion
- 2019-11-26
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.